Apyx Medical Corp DEF 14A: Executive Compensation Details

TL;DR

Apyx Medical Corp DEF 14A out: exec comp & equity awards for 2023, 2022, 2021.

AI Summary

Apyx Medical Corp filed a DEF 14A on June 25, 2024, detailing executive compensation and corporate governance for the fiscal year ending December 31, 2023. The filing includes information on equity awards granted to its PEO and Non-PEO NEO members during 2023, 2022, and 2021.

Why It Matters

This filing provides transparency into how Apyx Medical Corp compensates its top executives, which can influence investor decisions and perceptions of company management.

Risk Assessment

Risk Level: low — This filing is a routine disclosure of executive compensation and corporate governance, not indicating immediate operational or financial risk.

Key Players & Entities

• Apyx Medical Corp (company) — Filer of the DEF 14A
• 2023-12-31 (date) — Fiscal year end
• 20240625 (date) — Filing date

FAQ

Key Financial Figures

• $23,000 — tation of proxies will be approximately $23,000 to be incurred solely by us. We will re

Filing Documents

• apyx-20240625.htm (DEF 14A) — 736KB
• apyx-20240625_g1.jpg (GRAPHIC) — 79KB
• apyx-20240625_g2.jpg (GRAPHIC) — 450KB
• apyx-20240625_g3.jpg (GRAPHIC) — 226KB
• 0000719135-24-000032.txt ( ) — 3124KB
• apyx-20240625.xsd (EX-101.SCH) — 5KB
• apyx-20240625_def.xml (EX-101.DEF) — 5KB
• apyx-20240625_lab.xml (EX-101.LAB) — 9KB
• apyx-20240625_pre.xml (EX-101.PRE) — 6KB
• apyx-20240625_htm.xml (XML) — 159KB

From the Filing

apyx-20240625 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant Filed by a party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a–6(e)(2)) Definitive Proxy Statement o Definitive Additional Materials o Soliciting Material Pursuant to Section 240.14a-12 APYX MEDICAL CORPORATION (Exact name of registrant as specified in its charter) N/A (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of filing fee (Check the appropriate box): No fee required. o Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11. o Fee paid previously with preliminary materials. APYX MEDICAL CORPORATION 5115 Ulmerton Road Clearwater, Florida 33760 NOTICE OF 2024 ANNUAL MEETING OF STOCKHOLDERS Dear Stockholders: On behalf of the Board of Directors (the "Board") of Apyx Medical Corporation (the "Company"), you are cordially invited to attend the 2024 Annual Meeting of Stockholders (the "Annual Meeting") to be held on August 8, 2024 at 9:00 a.m. Eastern Standard Time at the offices of Ruskin Moscou, Faltischek, P.C. located at 1425 RXR Plaza, East Tower, 15th Floor, Uniondale, New York 11556, Telephone No. (516) 663-6600. Information Concerning Solicitation and Voting The Board is soliciting proxies for the Annual Meeting to be held on August 8, 2024. This Proxy Statement contains information for you to consider when deciding how to vote on the matters brought before the An nual Meeting. A notice of internet availability of proxy materials is being mailed to stockholders on or about June 28, 2024. The executive office of our Company is located at 5115 Ulmerton Road, Clearwater, Florida 33760, telephone number (727) 384-2323. At the Annual Meeting, the Company's stockholders will be asked to: 1. Elect eight (8) directors to the Board to serve until the 2025 Annual Meeting of Stockholders (the "Director Proposal"); 2. Ratify RSM US LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2024 (the "Auditor Proposal"); and 3. Transact such other business that may properly come before the meeting. Stockholders are referred to the Proxy Statement accompanying this notice for more detailed information with respect to the matters to be considered at the Annual Meeting. After careful consideration, the Board unanimously recommends that you vote "FOR" the Board's nominees for the Director Proposal (Proposal 1); "FOR" the Auditor Proposal (Proposal 2); and, in the proxy holder's best judgment, as to any other matters that may properly come before the Annual Meeting. All stockholders are invited to attend the Annual Meeting. The close of business on June 13, 2024 is the record date for determining stockholders entitled to notice of, and to vote at, the Annual Meeting. Consequently, only stockholders whose names appear on our books as owning our common stock at the close of business on June 13, 2024 will be entitled to notice of, and to vote at, the Annual Meeting and any adjournment or postponement thereof. YOUR VOTE AND PARTICIPATION IN THE COMPANY'S AFFAIRS ARE IMPORTANT. If your shares are registered in your name , even if you plan to attend the Annual Meeting or any adjournment or postponement of the Annual Meeting in person, we request that you vote by telephone, over the Internet, or complete, sign and mail your proxy card to ensure that your shares will be represented at the Annual Meeting. If your shares are held in the name of a broker, bank or other nominee , and you receive notice of the Annual Meeting through your broker, bank or other nominee, please vote or complete and return the materials in accordance with the instructions provided to you by such broker, bank or other nominee or contact your broker, bank or other nominee directly in order to obtain a proxy issued to you by your nominee holder to attend the Annual Meeting and vote in person. Failure to do so may result in your shares not being eligible to be voted by proxy at the Annual Meeting. The accompanying Proxy Statement contains important information concerning the Annual Meeting, including information as to how to cast your vote. We encourage you to read the accompanying Proxy Statement and other annexes to the Proxy Statement carefully and in their entirety. Your vote is important to us. Please complete, sign, date and promptly return the proxy card, vote online or vote by phone, so that your shares will be represented whether or not you attend the Annual Meeting. Returning a proxy card will not deprive you of your right to attend the Annual Meeting and vote your shares in person. IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE ANNUAL

View Full Filing

View this DEF 14A filing on SEC EDGAR